Table 3.
No. | Method | Fivefold Cross-Validation |
---|---|---|
1 | CT_all | 0.659 ± 0.063 |
2 | CT_only_tumour | 0.627 ± 0.062 |
3 | CT_largest_tumour | 0.587 ± 0.040 |
4 | CT_only_lymph_node | 0.608 ± 0.059 |
5 | CT_largest_lymph_node | 0.605 ± 0.060 |
6 | PET_all | 0.622 ± 0.077 |
7 | PET_only_tumour | 0.603 ± 0.065 |
8 | PET_largest_tumour | 0.569 ± 0.054 |
9 | PET_only_lymph_node | 0.635 ± 0.074 |
10 | PET_largest_lymph_node | 0.644 ± 0.084 |
11 | volume | 0.598 ± 0.051 |
12 | clinical | 0.552 ± 0.032 |
13 | radiomics_clinical | 0.682 ± 0.083 |
No. | Method | Test Set |
1 | radiomics_clinical | 0.672 |